216 related articles for article (PubMed ID: 6208106)
1. [Immunologic problems in allogenic and autologous bone marrow transplantation].
Schwenke H; Helbig W; Kubel M; Schultze W
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(2):217-23. PubMed ID: 6208106
[No Abstract] [Full Text] [Related]
2. Bone marrow transplantation.
Storb R; Santos GW
Transplant Proc; 1979 Mar; 11(1):1163-6. PubMed ID: 36699
[No Abstract] [Full Text] [Related]
3. Effector cells of graft-versus-host disease, host resistance, and the graft-versus-leukemia effect: summary of a workshop on bone marrow transplantation.
Ringdén O; Deeg HJ; Beschorner W; Slavin S
Transplant Proc; 1987 Feb; 19(1 Pt 3):2758-61. PubMed ID: 3547953
[No Abstract] [Full Text] [Related]
4. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
Galili U
Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
[TBL] [Abstract][Full Text] [Related]
5. Marrow transplantation for the treatment of acute leukemia using HL-A-identical siblings.
Buckner CD; Clift RA; Fefer A; Lerner KG; Neiman PE; Storb R; Thomas ED
Transplant Proc; 1974 Dec; 6(4):365-6. PubMed ID: 4612892
[No Abstract] [Full Text] [Related]
6. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
Li JM; Waller EK
Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
Talmadge JE
Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
[TBL] [Abstract][Full Text] [Related]
8. Effective graft-versus-leukemia effects independent of graft-versus-host disease after T cell-depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2.
Weiss L; Lubin I; Factorowich I; Lapidot Z; Reich S; Reisner Y; Slavin S
J Immunol; 1994 Sep; 153(6):2562-7. PubMed ID: 8077666
[TBL] [Abstract][Full Text] [Related]
9. Composite vascularized skin/bone transplantation models for bone marrow-based tolerance studies.
Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Siemionow M
Ann Plast Surg; 2006 Mar; 56(3):295-300. PubMed ID: 16508361
[TBL] [Abstract][Full Text] [Related]
10. Approaches to graft-versus-host disease following bone marrow transplantation in monkeys and man.
Dicke KA; Spitzer G; Peters L; Stevens EE; Hendriks W; McCredie tkb
Transplant Proc; 1978 Mar; 10(1):217-21. PubMed ID: 416529
[No Abstract] [Full Text] [Related]
11. Modulation of graft-versus-host disease: role of regulatory T lymphocytes.
Hess AD
Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):13-21. PubMed ID: 16399597
[TBL] [Abstract][Full Text] [Related]
12. Expression of T cell activation antigen CD134 (OX40) has no predictive value for the occurrence or response to therapy of acute graft-versus-host disease in partial T cell-depleted bone marrow transplantation.
Gadisseur AP; Gratama JW; Lamers C; van Esser JW; Bolhuis RL; Cornelissen JJ
Bone Marrow Transplant; 1999 May; 23(10):1013-7. PubMed ID: 10373067
[TBL] [Abstract][Full Text] [Related]
13. [Bone marrow transplantation during radiation and chemotherapy of patients with malignant tumors].
Shevchenko VS
Vopr Onkol; 1966; 12(9):112-23. PubMed ID: 4881112
[No Abstract] [Full Text] [Related]
14. Mechanisms of tolerance in marrow transplantation.
Deeg HJ; Tsoi MS; Storb R
Transplant Proc; 1984 Aug; 16(4):933-7. PubMed ID: 6235653
[No Abstract] [Full Text] [Related]
15. [Immunosuppression and the problems in homologous bone marrow transplantation].
Yabe H; Kato S
Nihon Rinsho Meneki Gakkai Kaishi; 1995 Dec; 18(6):681-2. PubMed ID: 8963784
[No Abstract] [Full Text] [Related]
16. Graft failure and graft-vs-host disease after subtotal T-cell-depleted marrow transplantation: correlations with marrow hematopoietic and lymphoid subsets.
Przepiorka D; Huh YO; Khouri I; Reading C; Hester J; Marshall M; Champlin RE
Prog Clin Biol Res; 1994; 389():557-63. PubMed ID: 7700921
[No Abstract] [Full Text] [Related]
17. Renal transplantation without immunosuppression in a host with tolerance induced by allogeneic bone marrow transplantation.
Helg C; Chapuis B; Bolle JF; Morel P; Salomon D; Roux E; Antonioli V; Jeannet M; Leski M
Transplantation; 1994 Dec; 58(12):1420-2. PubMed ID: 7809937
[No Abstract] [Full Text] [Related]
18. The impact of partial T cell depletion on overall transplant-related toxicity, graft function and survival after HLA-identical allogeneic bone marrow transplantation in standard risk adult patients with leukemia.
Schots R; Van Riet I; Ben Othman T; Trullemans F; De Waele M; Van Camp B
Bone Marrow Transplant; 2001 Nov; 28(10):917-22. PubMed ID: 11753544
[TBL] [Abstract][Full Text] [Related]
19. [Bone marrow transplantation].
Rozman C
Rev Hosp Clin Fac Med Sao Paulo; 1985; 40(3):125-40. PubMed ID: 3912945
[No Abstract] [Full Text] [Related]
20. Immunoglobulin synthesis after HLA-identical marrow grafting. V. The role of peripheral blood monocytes in the regulation of in vitro immunoglobulin secretion stimulated by pokeweed mitogen.
Shiobara S; Witherspoon RP; Lum LG; Storb R
J Immunol; 1984 Jun; 132(6):2850-6. PubMed ID: 6373919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
